25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Zhuhai Rundu Pharmaceutical Co Ltd Class A
Buy, Hold or Sell?

Let's analyze Zhuhai Rundu Pharmaceutical Co Ltd Class A together

I guess you are interested in Zhuhai Rundu Pharmaceutical Co Ltd Class A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhuhai Rundu Pharmaceutical Co Ltd Class A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Zhuhai Rundu Pharmaceutical Co Ltd Class A

I send you an email if I find something interesting about Zhuhai Rundu Pharmaceutical Co Ltd Class A.

1. Quick Overview

1.1. Quick analysis of Zhuhai Rundu Pharmaceutical Co Ltd Class A (30 sec.)










1.2. What can you expect buying and holding a share of Zhuhai Rundu Pharmaceutical Co Ltd Class A? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.43
Expected worth in 1 year
¥3.34
How sure are you?
95.5%

+ What do you gain per year?

Total Gains per Share
¥0.15
Return On Investment
1.7%

For what price can you sell your share?

Current Price per Share
¥9.26
Expected price per share
¥8.96 - ¥10.91
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Zhuhai Rundu Pharmaceutical Co Ltd Class A (5 min.)




Live pricePrice per Share (EOD)
¥9.26
Intrinsic Value Per Share
¥14.27 - ¥17.24
Total Value Per Share
¥17.71 - ¥20.67

2.2. Growth of Zhuhai Rundu Pharmaceutical Co Ltd Class A (5 min.)




Is Zhuhai Rundu Pharmaceutical Co Ltd Class A growing?

Current yearPrevious yearGrowGrow %
How rich?$161.4m$166.9m-$1.4m-0.9%

How much money is Zhuhai Rundu Pharmaceutical Co Ltd Class A making?

Current yearPrevious yearGrowGrow %
Making money$1.2m$5.2m-$4m-322.1%
Net Profit Margin2.9%10.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Zhuhai Rundu Pharmaceutical Co Ltd Class A (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Zhuhai Rundu Pharmaceutical Co Ltd Class A?

Welcome investor! Zhuhai Rundu Pharmaceutical Co Ltd Class A's management wants to use your money to grow the business. In return you get a share of Zhuhai Rundu Pharmaceutical Co Ltd Class A.

First you should know what it really means to hold a share of Zhuhai Rundu Pharmaceutical Co Ltd Class A. And how you can make/lose money.

Speculation

The Price per Share of Zhuhai Rundu Pharmaceutical Co Ltd Class A is ¥9.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhuhai Rundu Pharmaceutical Co Ltd Class A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.43. Based on the TTM, the Book Value Change Per Share is ¥-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhuhai Rundu Pharmaceutical Co Ltd Class A.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.000.0%0.010.2%0.010.1%0.010.1%
Usd Book Value Change Per Share-0.02-0.3%0.000.0%0.010.1%0.010.1%0.020.2%
Usd Dividend Per Share0.030.3%0.010.1%0.030.3%0.010.2%0.010.2%
Usd Total Gains Per Share0.010.1%0.010.1%0.040.4%0.020.2%0.040.4%
Usd Price Per Share1.30-1.59-2.32-2.48-2.56-
Price to Earnings Ratio88.65-148.22-43.12-70.22-69.54-
Price-to-Total Gains Ratio237.33--3,270.61-97.55--535.04--478.20-
Price to Book Ratio2.70-3.22-4.65-5.49-5.80-
Price-to-Total Gains Ratio237.33--3,270.61-97.55--535.04--478.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.300104
Number of shares769
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.010.02
Gains per Quarter (769 shares)4.1515.39
Gains per Year (769 shares)16.6261.57
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
127-107441852
254-20248736114
380-304113154176
4107-415817472238
5134-517521890300
6161-6192261108362
7187-71109305126424
8214-81126348144486
9241-91143392162548
10268-102160435180610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%21.01.00.095.5%21.01.00.095.5%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%14.06.00.070.0%15.07.00.068.2%15.07.00.068.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%22.00.00.0100.0%22.00.00.0100.0%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%21.01.00.095.5%21.01.00.095.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Zhuhai Rundu Pharmaceutical Co Ltd Class A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.174-0.024-86%0.051-440%0.042-516%0.156-211%
Book Value Per Share--3.4343.520-2%3.550-3%3.268+5%3.212+7%
Current Ratio--1.9941.9990%1.869+7%2.235-11%2.328-14%
Debt To Asset Ratio--0.4650.468-1%0.461+1%0.396+17%0.387+20%
Debt To Equity Ratio--0.8680.879-1%0.858+1%0.676+28%0.653+33%
Dividend Per Share--0.2130.062+243%0.201+6%0.101+111%0.101+111%
Eps--0.0260.026-1%0.103-75%0.086-70%0.087-70%
Free Cash Flow Per Share--0.1170.064+83%0.000+100%-0.045+139%-0.049+141%
Free Cash Flow To Equity Per Share--0.1170.058+102%-0.120+203%-0.049+141%-0.051+144%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--17.237--------
Intrinsic Value_10Y_min--14.271--------
Intrinsic Value_1Y_max--0.170--------
Intrinsic Value_1Y_min--0.166--------
Intrinsic Value_3Y_max--1.698--------
Intrinsic Value_3Y_min--1.597--------
Intrinsic Value_5Y_max--4.656--------
Intrinsic Value_5Y_min--4.219--------
Market Cap3101109105.9200%3101111828.3603791829230.735-18%5534109069.055-44%5921247481.496-48%6102970666.465-49%
Net Profit Margin--0.0300.029+4%0.108-72%0.092-67%0.092-67%
Operating Margin---0.002-100%0.118-100%0.089-100%0.091-100%
Operating Ratio--1.4411.426+1%1.296+11%1.293+11%1.282+12%
Pb Ratio2.6970%2.6973.215-16%4.650-42%5.488-51%5.800-54%
Pe Ratio88.6470%88.647148.215-40%43.119+106%70.225+26%69.539+27%
Price Per Share9.2600%9.26011.323-18%16.525-44%17.681-48%18.224-49%
Price To Free Cash Flow Ratio19.7260%19.7267.591+160%-0.427+102%3.664+438%-16.798+185%
Price To Total Gains Ratio237.3280%237.328-3270.607+1478%97.547+143%-535.039+325%-478.196+301%
Quick Ratio--0.3400.819-58%0.831-59%1.133-70%1.164-71%
Return On Assets--0.0040.004+2%0.017-76%0.017-76%0.018-77%
Return On Equity--0.0080.007+3%0.031-76%0.027-72%0.028-73%
Total Gains Per Share--0.0390.038+1%0.252-85%0.143-73%0.257-85%
Usd Book Value--161463485.271165504204.270-2%166937151.139-3%153674240.606+5%151004888.017+7%
Usd Book Value Change Per Share---0.024-0.003-86%0.007-440%0.006-516%0.022-211%
Usd Book Value Per Share--0.4820.494-2%0.498-3%0.459+5%0.451+7%
Usd Dividend Per Share--0.0300.009+243%0.028+6%0.014+111%0.014+111%
Usd Eps--0.0040.004-1%0.014-75%0.012-70%0.012-70%
Usd Free Cash Flow--5518136.2683014455.274+83%-20472.189+100%-2137211.585+139%-2284833.151+141%
Usd Free Cash Flow Per Share--0.0160.009+83%0.000+100%-0.006+139%-0.007+141%
Usd Free Cash Flow To Equity Per Share--0.0160.008+102%-0.017+203%-0.007+141%-0.007+144%
Usd Market Cap435395718.4710%435396100.702532372823.995-18%776988913.295-44%831343146.402-48%856857081.572-49%
Usd Price Per Share1.3000%1.3001.590-18%2.320-44%2.482-48%2.559-49%
Usd Profit--1227888.8891244230.594-1%5252141.860-77%4137475.124-70%4178192.281-71%
Usd Revenue--40866559.39543299954.770-6%48045041.778-15%44738449.540-9%45079589.837-9%
Usd Total Gains Per Share--0.0050.005+1%0.035-85%0.020-73%0.036-85%
 EOD+0 -2MRQTTM+18 -17YOY+11 -245Y+13 -2210Y+13 -22

3.3 Fundamental Score

Let's check the fundamental score of Zhuhai Rundu Pharmaceutical Co Ltd Class A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1588.647
Price to Book Ratio (EOD)Between0-12.697
Net Profit Margin (MRQ)Greater than00.030
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.340
Current Ratio (MRQ)Greater than11.994
Debt to Asset Ratio (MRQ)Less than10.465
Debt to Equity Ratio (MRQ)Less than10.868
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.004
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Zhuhai Rundu Pharmaceutical Co Ltd Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.700
Ma 20Greater thanMa 509.439
Ma 50Greater thanMa 1008.862
Ma 100Greater thanMa 2009.089
OpenGreater thanClose9.410
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Zhuhai Rundu Pharmaceutical Co Ltd Class A

Zhuhai Rundu Pharmaceutical Co., Ltd. develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, and CNS worldwide. It offers APIs, intermediates, FDF, and pellets. The company was founded in 1997 and is headquartered in Zhuhai, China.

Fundamental data was last updated by Penke on 2024-10-15 01:10:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Zhuhai Rundu Pharmaceutical Co Ltd Class A earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhuhai Rundu Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 3.0% means that ¥0.03 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The MRQ is 3.0%. The company is making a profit. +1
  • The TTM is 2.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.0%TTM2.9%+0.1%
TTM2.9%YOY10.8%-7.9%
TTM2.9%5Y9.2%-6.3%
5Y9.2%10Y9.2%0.0%
4.3.1.2. Return on Assets

Shows how efficient Zhuhai Rundu Pharmaceutical Co Ltd Class A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhuhai Rundu Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.4% Return on Assets means that Zhuhai Rundu Pharmaceutical Co Ltd Class A generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.4%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.4%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM0.4%+0.0%
TTM0.4%YOY1.7%-1.3%
TTM0.4%5Y1.7%-1.3%
5Y1.7%10Y1.8%-0.1%
4.3.1.3. Return on Equity

Shows how efficient Zhuhai Rundu Pharmaceutical Co Ltd Class A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhuhai Rundu Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.8% Return on Equity means Zhuhai Rundu Pharmaceutical Co Ltd Class A generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.7%+0.0%
TTM0.7%YOY3.1%-2.4%
TTM0.7%5Y2.7%-2.0%
5Y2.7%10Y2.8%-0.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Zhuhai Rundu Pharmaceutical Co Ltd Class A.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Zhuhai Rundu Pharmaceutical Co Ltd Class A is operating .

  • Measures how much profit Zhuhai Rundu Pharmaceutical Co Ltd Class A makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhuhai Rundu Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.2%-0.2%
TTM0.2%YOY11.8%-11.6%
TTM0.2%5Y8.9%-8.8%
5Y8.9%10Y9.1%-0.2%
4.3.2.2. Operating Ratio

Measures how efficient Zhuhai Rundu Pharmaceutical Co Ltd Class A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.44 means that the operating costs are ¥1.44 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The MRQ is 1.441. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.426. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.441TTM1.426+0.014
TTM1.426YOY1.296+0.131
TTM1.4265Y1.293+0.133
5Y1.29310Y1.282+0.011
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Zhuhai Rundu Pharmaceutical Co Ltd Class A.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Zhuhai Rundu Pharmaceutical Co Ltd Class A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.99 means the company has ¥1.99 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The MRQ is 1.994. The company is able to pay all its short-term debts. +1
  • The TTM is 1.999. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.994TTM1.999-0.005
TTM1.999YOY1.869+0.130
TTM1.9995Y2.235-0.236
5Y2.23510Y2.328-0.092
4.4.3.2. Quick Ratio

Measures if Zhuhai Rundu Pharmaceutical Co Ltd Class A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhuhai Rundu Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.34 means the company can pay off ¥0.34 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.340. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.819. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.340TTM0.819-0.479
TTM0.819YOY0.831-0.011
TTM0.8195Y1.133-0.314
5Y1.13310Y1.164-0.031
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Zhuhai Rundu Pharmaceutical Co Ltd Class A.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Zhuhai Rundu Pharmaceutical Co Ltd Class A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhuhai Rundu Pharmaceutical Co Ltd Class A to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.46 means that Zhuhai Rundu Pharmaceutical Co Ltd Class A assets are financed with 46.5% credit (debt) and the remaining percentage (100% - 46.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.465. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.468. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.465TTM0.468-0.003
TTM0.468YOY0.461+0.006
TTM0.4685Y0.396+0.072
5Y0.39610Y0.387+0.009
4.5.4.2. Debt to Equity Ratio

Measures if Zhuhai Rundu Pharmaceutical Co Ltd Class A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhuhai Rundu Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 86.8% means that company has ¥0.87 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.868. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.879. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.868TTM0.879-0.012
TTM0.879YOY0.858+0.022
TTM0.8795Y0.676+0.203
5Y0.67610Y0.653+0.024
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhuhai Rundu Pharmaceutical Co Ltd Class A generates.

  • Above 15 is considered overpriced but always compare Zhuhai Rundu Pharmaceutical Co Ltd Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 88.65 means the investor is paying ¥88.65 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The EOD is 88.647. Based on the earnings, the company is expensive. -2
  • The MRQ is 88.647. Based on the earnings, the company is expensive. -2
  • The TTM is 148.215. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD88.647MRQ88.6470.000
MRQ88.647TTM148.215-59.568
TTM148.215YOY43.119+105.096
TTM148.2155Y70.225+77.990
5Y70.22510Y69.539+0.686
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The EOD is 19.726. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 19.726. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 7.591. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD19.726MRQ19.7260.000
MRQ19.726TTM7.591+12.135
TTM7.591YOY-0.427+8.017
TTM7.5915Y3.664+3.927
5Y3.66410Y-16.798+20.462
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Zhuhai Rundu Pharmaceutical Co Ltd Class A is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhuhai Rundu Pharmaceutical Co Ltd Class A:

  • The EOD is 2.697. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.697. Based on the equity, the company is underpriced. +1
  • The TTM is 3.215. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.697MRQ2.6970.000
MRQ2.697TTM3.215-0.519
TTM3.215YOY4.650-1.434
TTM3.2155Y5.488-2.272
5Y5.48810Y5.800-0.312
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,147,997
Total Liabilities997,972
Total Stockholder Equity1,150,025
 As reported
Total Liabilities 997,972
Total Stockholder Equity+ 1,150,025
Total Assets = 2,147,997

Assets

Total Assets2,147,997
Total Current Assets796,238
Long-term Assets1,351,758
Total Current Assets
Cash And Cash Equivalents 127,100
Short-term Investments 54
Net Receivables 135,851
Inventory 444,909
Other Current Assets 5,012
Total Current Assets  (as reported)796,238
Total Current Assets  (calculated)712,926
+/- 83,312
Long-term Assets
Property Plant Equipment 1,240,529
Intangible Assets 65,272
Long-term Assets Other 17,610
Long-term Assets  (as reported)1,351,758
Long-term Assets  (calculated)1,323,411
+/- 28,347

Liabilities & Shareholders' Equity

Total Current Liabilities399,323
Long-term Liabilities598,648
Total Stockholder Equity1,150,025
Total Current Liabilities
Short Long Term Debt 13,011
Accounts payable 174,681
Other Current Liabilities 14,695
Total Current Liabilities  (as reported)399,323
Total Current Liabilities  (calculated)202,386
+/- 196,937
Long-term Liabilities
Long term Debt 433,695
Capital Lease Obligations Min Short Term Debt6,454
Long-term Liabilities Other 1,096
Long-term Liabilities  (as reported)598,648
Long-term Liabilities  (calculated)441,246
+/- 157,403
Total Stockholder Equity
Retained Earnings 501,644
Total Stockholder Equity (as reported)1,150,025
Total Stockholder Equity (calculated)501,644
+/- 648,380
Other
Capital Stock334,893
Common Stock Shares Outstanding 334,893
Net Debt 319,606
Net Invested Capital 1,596,731
Net Working Capital 396,915
Property Plant and Equipment Gross 1,733,692



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-312015-06-30
> Total Assets 
385,207
499,719
616,603
641,358
649,122
706,004
1,048,458
1,021,359
1,086,959
1,138,420
1,224,803
1,281,173
1,314,916
1,326,680
1,428,111
1,401,343
1,464,324
1,513,772
1,625,348
1,651,166
1,714,137
1,909,438
1,975,467
1,995,847
2,066,081
2,286,350
2,260,734
2,222,924
2,249,778
2,227,774
2,236,014
2,147,997
2,147,9972,236,0142,227,7742,249,7782,222,9242,260,7342,286,3502,066,0811,995,8471,975,4671,909,4381,714,1371,651,1661,625,3481,513,7721,464,3241,401,3431,428,1111,326,6801,314,9161,281,1731,224,8031,138,4201,086,9591,021,3591,048,458706,004649,122641,358616,603499,719385,207
   > Total Current Assets 
195,334
248,322
324,888
343,214
355,181
407,462
745,582
710,236
750,983
774,755
830,075
811,416
794,571
781,099
869,495
802,774
804,848
777,785
835,789
780,140
764,615
808,137
825,189
804,309
811,719
946,246
916,719
873,926
913,304
866,733
871,628
796,238
796,238871,628866,733913,304873,926916,719946,246811,719804,309825,189808,137764,615780,140835,789777,785804,848802,774869,495781,099794,571811,416830,075774,755750,983710,236745,582407,462355,181343,214324,888248,322195,334
       Cash And Cash Equivalents 
57,179
104,576
149,529
154,951
0
168,095
485,866
169,134
77,331
182,501
184,395
188,871
249,364
197,824
224,862
323,399
251,699
251,682
267,119
245,333
273,769
250,302
189,091
127,419
101,851
221,032
195,499
169,819
205,253
213,859
203,299
127,100
127,100203,299213,859205,253169,819195,499221,032101,851127,419189,091250,302273,769245,333267,119251,682251,699323,399224,862197,824249,364188,871184,395182,50177,331169,134485,866168,0950154,951149,529104,57657,179
       Short-term Investments 
-6,856
-10,641
-10,847
-10,720
0
-14,675
-13,451
-12,524
-11,438
-10,392
-9,281
-24,557
-22,091
-19,617
-17,160
-15,824
-13,568
44,011
20,031
10,005
500
87
79
67
51
62
59
56
52
52
20,061
54
5420,06152525659625167798750010,00520,03144,011-13,568-15,824-17,160-19,617-22,091-24,557-9,281-10,392-11,438-12,524-13,451-14,6750-10,720-10,847-10,641-6,856
       Net Receivables 
74,251
84,282
91,694
86,478
0
114,899
138,273
148,013
170,528
143,168
202,572
204,608
188,047
203,878
239,656
195,552
195,976
171,034
234,979
171,933
164,469
186,115
213,368
206,278
226,443
226,959
217,143
226,685
227,887
212,112
193,734
135,851
135,851193,734212,112227,887226,685217,143226,959226,443206,278213,368186,115164,469171,933234,979171,034195,976195,552239,656203,878188,047204,608202,572143,168170,528148,013138,273114,899086,47891,69484,28274,251
       Inventory 
67,864
63,381
83,148
101,612
0
122,827
127,991
149,724
161,124
171,114
175,494
225,162
225,133
239,651
223,693
278,691
271,402
302,002
303,691
330,654
297,726
335,527
380,669
417,958
427,609
440,855
435,694
475,062
474,134
415,455
426,360
444,909
444,909426,360415,455474,134475,062435,694440,855427,609417,958380,669335,527297,726330,654303,691302,002271,402278,691223,693239,651225,133225,162175,494171,114161,124149,724127,991122,8270101,61283,14863,38167,864
   > Long-term Assets 
189,873
251,397
291,716
298,145
293,941
298,542
302,876
311,123
335,976
363,665
394,728
469,757
520,345
545,581
558,616
598,569
659,476
735,988
789,559
871,026
949,522
1,101,301
1,150,277
1,191,538
1,254,362
1,340,104
1,344,015
1,348,999
1,336,475
1,361,040
1,364,386
1,351,758
1,351,7581,364,3861,361,0401,336,4751,348,9991,344,0151,340,1041,254,3621,191,5381,150,2771,101,301949,522871,026789,559735,988659,476598,569558,616545,581520,345469,757394,728363,665335,976311,123302,876298,542293,941298,145291,716251,397189,873
       Property Plant Equipment 
150,147
209,251
252,666
259,557
0
248,418
244,841
249,843
271,610
309,380
340,249
352,117
368,766
440,442
461,727
489,940
525,848
581,993
619,797
712,223
783,074
972,572
991,957
1,045,892
1,127,910
1,223,722
1,200,391
1,194,890
1,188,866
1,249,617
1,257,020
1,240,529
1,240,5291,257,0201,249,6171,188,8661,194,8901,200,3911,223,7221,127,9101,045,892991,957972,572783,074712,223619,797581,993525,848489,940461,727440,442368,766352,117340,249309,380271,610249,843244,841248,4180259,557252,666209,251150,147
       Intangible Assets 
24,662
24,383
23,825
23,547
0
23,268
23,128
22,989
22,850
22,710
22,571
50,677
50,396
50,115
49,834
56,508
65,839
65,475
72,479
72,147
71,746
68,997
70,608
68,397
68,006
67,616
67,225
66,834
66,444
66,053
65,662
65,272
65,27265,66266,05366,44466,83467,22567,61668,00668,39770,60868,99771,74672,14772,47965,47565,83956,50849,83450,11550,39650,67722,57122,71022,85022,98923,12823,268023,54723,82524,38324,662
       Long-term Assets Other 
5,731
4,403
1,265
665
293,941
4,208
15,936
17,977
23,635
15,410
18,349
35,784
71,242
25,565
19,922
24,550
40,117
120,386
103,173
82,883
84,592
50,705
77,887
68,311
47,642
38,100
65,310
77,318
72,053
34,198
30,328
17,610
17,61030,32834,19872,05377,31865,31038,10047,64268,31177,88750,70584,59282,883103,173120,38640,11724,55019,92225,56571,24235,78418,34915,41023,63517,97715,9364,208293,9416651,2654,4035,731
> Total Liabilities 
109,059
188,997
218,416
196,896
182,345
217,164
194,048
204,729
241,651
267,125
324,522
410,637
403,025
386,386
448,313
432,184
455,773
475,539
549,988
603,381
641,027
797,283
825,159
882,840
923,950
1,090,366
1,024,318
1,041,411
1,071,959
1,048,614
1,027,798
997,972
997,9721,027,7981,048,6141,071,9591,041,4111,024,3181,090,366923,950882,840825,159797,283641,027603,381549,988475,539455,773432,184448,313386,386403,025410,637324,522267,125241,651204,729194,048217,164182,345196,896218,416188,997109,059
   > Total Current Liabilities 
79,559
109,275
108,991
110,547
101,529
112,103
94,970
111,141
123,695
150,664
215,461
306,163
307,171
293,872
361,962
349,672
359,505
360,779
311,771
253,937
277,397
422,868
341,647
390,591
420,739
589,741
458,824
449,572
463,788
446,312
417,172
399,323
399,323417,172446,312463,788449,572458,824589,741420,739390,591341,647422,868277,397253,937311,771360,779359,505349,672361,962293,872307,171306,163215,461150,664123,695111,14194,970112,103101,529110,547108,991109,27579,559
       Short-term Debt 
30,000
43,000
33,000
41,480
0
37,960
17,960
17,960
17,960
17,960
17,960
17,960
17,960
18,186
75,960
73,340
71,610
67,150
39,080
40,519
33,095
35,524
5,064
52,480
59,705
89,966
97,566
113,959
128,877
131,472
141,154
0
0141,154131,472128,877113,95997,56689,96659,70552,4805,06435,52433,09540,51939,08067,15071,61073,34075,96018,18617,96017,96017,96017,96017,96017,96017,96037,960041,48033,00043,00030,000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
226
58,000
58,280
58,000
58,030
33,000
33,000
30,000
33,000
3,000
49,980
57,699
62,936
62,565
88,072
86,070
60,541
66,058
13,011
13,01166,05860,54186,07088,07262,56562,93657,69949,9803,00033,00030,00033,00033,00058,03058,00058,28058,0002260000000000000
       Accounts payable 
21,702
30,385
38,412
32,052
0
22,432
28,902
18,151
15,853
18,850
40,704
21,895
21,642
46,184
50,599
39,363
34,259
91,340
41,193
40,726
37,239
152,497
80,696
99,125
137,074
213,413
167,563
155,884
158,132
153,792
139,821
174,681
174,681139,821153,792158,132155,884167,563213,413137,07499,12580,696152,49737,23940,72641,19391,34034,25939,36350,59946,18421,64221,89540,70418,85015,85318,15128,90222,432032,05238,41230,38521,702
       Other Current Liabilities 
5,727
11,904
16,409
13,677
101,529
17,612
18,921
16,174
11,966
19,247
7,459
14,636
11,720
19,410
17,960
15,060
13,610
1,690
1,466
678
207,062
234,847
255,887
238,986
215,023
239,678
193,696
18,571
20,720
7,456
11,429
14,695
14,69511,4297,45620,72018,571193,696239,678215,023238,986255,887234,847207,0626781,4661,69013,61015,06017,96019,41011,72014,6367,45919,24711,96616,17418,92117,612101,52913,67716,40911,9045,727
   > Long-term Liabilities 
29,500
79,722
109,425
86,350
80,816
105,061
99,078
93,588
117,955
116,462
109,060
104,474
95,854
92,514
86,351
82,513
96,268
114,759
238,217
349,444
363,630
374,414
483,512
492,249
503,211
500,624
565,493
591,840
608,171
602,303
610,627
598,648
598,648610,627602,303608,171591,840565,493500,624503,211492,249483,512374,414363,630349,444238,217114,75996,26882,51386,35192,51495,854104,474109,060116,462117,95593,58899,078105,06180,81686,350109,42579,72229,500
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
84,245
84,149
80,018
81,168
79,495
77,247
94,042
112,534
109,999
107,554
121,886
123,332
125,867
124,418
121,520
0
0
126,463
161,870
0
0
0
000161,870126,46300121,520124,418125,867123,332121,886107,554109,999112,53494,04277,24779,49581,16880,01884,14984,2450000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
9,281
24,557
22,091
19,617
17,160
15,824
13,568
14,892
13,007
10,485
8,270
13,311
14,064
12,809
13,788
0
34,229
39,918
38,807
0
0
0
00038,80739,91834,229013,78812,80914,06413,3118,27010,48513,00714,89213,56815,82417,16019,61722,09124,5579,2810000000000
> Total Stockholder Equity
276,148
310,721
398,187
444,462
466,776
488,840
854,410
816,630
845,308
871,295
900,281
870,536
911,891
940,295
979,799
969,158
1,008,551
1,038,234
1,075,361
1,047,785
1,073,110
1,112,156
1,150,308
1,113,007
1,142,131
1,195,984
1,236,416
1,181,513
1,177,819
1,179,159
1,208,216
1,150,025
1,150,0251,208,2161,179,1591,177,8191,181,5131,236,4161,195,9841,142,1311,113,0071,150,3081,112,1561,073,1101,047,7851,075,3611,038,2341,008,551969,158979,799940,295911,891870,536900,281871,295845,308816,630854,410488,840466,776444,462398,187310,721276,148
   Common Stock
75,000
75,000
75,000
75,000
0
75,000
100,000
120,000
120,000
120,000
120,000
185,420
185,420
185,420
185,420
185,939
185,912
185,912
185,870
185,870
185,710
185,710
185,679
241,383
239,209
239,209
239,209
334,893
334,893
334,893
334,893
0
0334,893334,893334,893334,893239,209239,209239,209241,383185,679185,710185,710185,870185,870185,912185,912185,939185,420185,420185,420185,420120,000120,000120,000120,000100,00075,000075,00075,00075,00075,000
   Retained Earnings 
148,756
176,343
255,178
301,453
0
345,831
365,791
328,011
356,689
372,637
401,624
363,788
397,053
405,432
440,579
407,421
441,903
452,660
487,736
442,927
467,115
503,905
542,057
504,757
533,880
564,956
605,388
550,485
546,791
530,784
559,839
501,644
501,644559,839530,784546,791550,485605,388564,956533,880504,757542,057503,905467,115442,927487,736452,660441,903407,421440,579405,432397,053363,788401,624372,637356,689328,011365,791345,8310301,453255,178176,343148,756
   Capital Surplus 00000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
52,392
59,378
68,009
68,009
466,776
68,009
388,620
368,620
368,620
378,657
378,657
321,328
329,418
349,444
353,800
375,799
380,737
399,662
401,755
418,988
420,285
422,541
422,571
276,692
0
278,866
0
183,182
0
130,301
183,182
0
0183,182130,3010183,1820278,8660276,692422,571422,541420,285418,988401,755399,662380,737375,799353,800349,444329,418321,328378,657378,657368,620368,620388,62068,009466,77668,00968,00959,37852,392



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,291,887
Cost of Revenue-638,762
Gross Profit653,125653,125
 
Operating Income (+$)
Gross Profit653,125
Operating Expense-1,150,043
Operating Income141,844-496,918
 
Operating Expense (+$)
Research Development129,443
Selling General Administrative345,004
Selling And Marketing Expenses0
Operating Expense1,150,043474,448
 
Net Interest Income (+$)
Interest Income2,253
Interest Expense-16,117
Other Finance Cost-1,121
Net Interest Income-14,984
 
Pretax Income (+$)
Operating Income141,844
Net Interest Income-14,984
Other Non-Operating Income Expenses0
Income Before Tax (EBT)86,040141,844
EBIT - interestExpense = -16,117
66,899
83,015
Interest Expense16,117
Earnings Before Interest and Taxes (EBIT)0102,157
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax86,040
Tax Provision-19,141
Net Income From Continuing Ops66,89966,899
Net Income66,899
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net014,984
 

Technical Analysis of Zhuhai Rundu Pharmaceutical Co Ltd Class A
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The general trend of Zhuhai Rundu Pharmaceutical Co Ltd Class A is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhuhai Rundu Pharmaceutical Co Ltd Class A's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhuhai Rundu Pharmaceutical Co Ltd Class A.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 10.05 < 10.64 < 10.91.

The bearish price targets are: 9 > 8.96 > 8.96.

Tweet this
Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current macd is 0.19109881.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhuhai Rundu Pharmaceutical Co Ltd Class A price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Zhuhai Rundu Pharmaceutical Co Ltd Class A. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Zhuhai Rundu Pharmaceutical Co Ltd Class A price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Moving Average Convergence/Divergence (MACD) ChartZhuhai Rundu Pharmaceutical Co Ltd Class A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current adx is 34.90.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zhuhai Rundu Pharmaceutical Co Ltd Class A shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current sar is 10.28.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current rsi is 50.70. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Relative Strength Index (RSI) ChartZhuhai Rundu Pharmaceutical Co Ltd Class A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhuhai Rundu Pharmaceutical Co Ltd Class A price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Stochastic Oscillator ChartZhuhai Rundu Pharmaceutical Co Ltd Class A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current cci is -41.65845325.

Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Commodity Channel Index (CCI) ChartZhuhai Rundu Pharmaceutical Co Ltd Class A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current cmo is -7.14092648.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Chande Momentum Oscillator (CMO) ChartZhuhai Rundu Pharmaceutical Co Ltd Class A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current willr is -72.47706422.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zhuhai Rundu Pharmaceutical Co Ltd Class A is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Williams %R ChartZhuhai Rundu Pharmaceutical Co Ltd Class A Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhuhai Rundu Pharmaceutical Co Ltd Class A.

Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current atr is 0.33135066.

Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Average True Range (ATR) ChartZhuhai Rundu Pharmaceutical Co Ltd Class A Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current obv is 17,817,196.

Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily On-Balance Volume (OBV) ChartZhuhai Rundu Pharmaceutical Co Ltd Class A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhuhai Rundu Pharmaceutical Co Ltd Class A. The current mfi is 38.75.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Money Flow Index (MFI) ChartZhuhai Rundu Pharmaceutical Co Ltd Class A Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhuhai Rundu Pharmaceutical Co Ltd Class A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-06-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-24STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Zhuhai Rundu Pharmaceutical Co Ltd Class A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhuhai Rundu Pharmaceutical Co Ltd Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.700
Ma 20Greater thanMa 509.439
Ma 50Greater thanMa 1008.862
Ma 100Greater thanMa 2009.089
OpenGreater thanClose9.410
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Zhuhai Rundu Pharmaceutical Co Ltd Class A with someone you think should read this too:
  • Are you bullish or bearish on Zhuhai Rundu Pharmaceutical Co Ltd Class A? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhuhai Rundu Pharmaceutical Co Ltd Class A? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhuhai Rundu Pharmaceutical Co Ltd Class A

I send you an email if I find something interesting about Zhuhai Rundu Pharmaceutical Co Ltd Class A.


Comments

How you think about this?

Leave a comment

Stay informed about Zhuhai Rundu Pharmaceutical Co Ltd Class A.

Receive notifications about Zhuhai Rundu Pharmaceutical Co Ltd Class A in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.